Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Spire Healthcare GroupCHIX:SPIL -0.53%80 EV-to-OCF is 9.15 as of Aug. 11, 2026, which is 10% below its 10-year median of 10.16. GuruFocus rates CHIX:SPIL with a GF Score™ of 80/100 and a GF Value™ of £2.76 (Modestly Undervalued). The stock has 9 warning signs investors should review. Among 681 Healthcare Providers & Services companies, Spire Healthcare Group ranks worse than 51.54% on this metric.
EV-to-OCF is calculated as enterprise value divided by its cash flow from operations. As of today, Spire Healthcare Group's Enterprise Value is £2,215 Mil.
Spire Healthcare Group's Cash Flow from Operations for the trailing twelve months (TTM) ended in Dec. 2025 was £242 Mil. Therefore, Spire Healthcare Group's EV-to-OCF for today is 9.15.
The historical rank and industry rank for Spire Healthcare Group's EV-to-OCF or its related term are showing as below:
CHIX:SPIl'
s EV-to-OCF Range Over the Past 10 Years
Min: 6.39 Med: 10.16 Max: 17.1
Current: 9.16
During the past 13 years, the highest EV-to-OCF of Spire Healthcare Group was 17.10. The lowest was 6.39. And the median was 10.16.
CHIX:SPIl's EV-to-OCF is ranked worse than 51.54% of 681
companies
in the Healthcare Providers & Services industry
Industry Median: 8.95
vs CHIX:SPIl: 9.16
EV-to-OCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Spire Healthcare Group (CHIX:SPIl) EV-to-OCF Explanation
EV-to-OCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Spire Healthcare Group's PE Ratio (TTM) for today is calculated as:
Spire Healthcare Group's share price for today is £2.33.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Spire Healthcare Group's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 was £0.040.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Cash Flow from Operations is an important financial metric because it represents the cash generated from operating activities at a company's disposal. Companies with a low EV-to-OCF ratio, combined with a strong balance sheet are generally considered as undervalued.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Care Facilities subindustry, Spire Healthcare Group's EV-to-OCF, along with its competitors' market caps and EV-to-OCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Spire Healthcare Group EV-to-OCF vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Spire Healthcare Group's EV-to-OCF distribution charts can be found below:
* The bar in red indicates where Spire Healthcare Group's EV-to-OCF falls into.
Spire Healthcare Group's current Enterprise Value is £2,215 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Spire Healthcare Group's Cash Flow from Operations for the trailing twelve months (TTM) ended in Dec. 2025 was £242 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Spire Healthcare Group (CHIX:SPIL) has a EV-to-OCF of 9.15 as of Aug. 11, 2026. This is 10% below median its historical median of 10.16. Over the past decade, Spire Healthcare Group's EV-to-OCF has ranged from 6.39 to 17.10. According to the industry distribution chart, Spire Healthcare Group ranks #351 out of 681 companies in the Healthcare Providers & Services industry, placing it in the top 51.5%.
Is Spire Healthcare Group's EV-to-OCF too high?
Spire Healthcare Group's current EV-to-OCF of 9.15 is 10% below median its 10-year median of 10.16. Over the past 10 years, this metric has ranged from a low of 6.39 to a high of 17.10. The Healthcare Providers & Services industry median EV-to-OCF is 8.95. Spire Healthcare Group's value of 9.15 is 2.2% above this industry median. Based on the distribution chart, Spire Healthcare Group ranks #351 out of 681 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, Spire Healthcare Group has a GF Score™ of 80/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Spire Healthcare Group's EV-to-OCF compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Spire Healthcare Group ranks #351 out of 681 companies for EV-to-OCF. This places Spire Healthcare Group in the lower half of its industry. The industry median EV-to-OCF is 8.95. Spire Healthcare Group's value of 9.15 is 2.2% above this benchmark. Historically, Spire Healthcare Group's own EV-to-OCF has ranged from 6.39 to 17.10 over the past decade. While the company's 10-year median is 10.16 vs. the industry median of 8.95, Spire Healthcare Group has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-OCF for a Healthcare Providers & Services company?
The median EV-to-OCF among Healthcare Providers & Services companies is 8.95, based on 681 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-OCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-OCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Spire Healthcare Group's current EV-to-OCF of 9.15 is 2.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-OCF mean?
A high EV-to-OCF can signal that a stock is expensive relative to its fundamentals. For the Healthcare Providers & Services industry, the median EV-to-OCF is 8.95 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Spire Healthcare Group's current EV-to-OCF is 9.15, which is 10% below median its own 10-year median of 10.16. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Spire Healthcare Group stock overvalued right now?
Based on GuruFocus' analysis, Spire Healthcare Group (CHIX:SPIL) is currently considered Modestly Undervalued. The stock's GF Value™ is £2.76, compared to a current price of £2.33 — trading 15.6% below its estimated fair value. The current EV-to-OCF is 9.15, which is 10% below median its 10-year median of 10.16 and 2.2% above the Healthcare Providers & Services industry median of 8.95. Spire Healthcare Group's overall GF Score™ is 80/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-OCF calculated?
EV-to-OCF is calculated from a company's financial statements. For Spire Healthcare Group (CHIX:SPIL), the current EV-to-OCF is 9.15 as of Aug. 11, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Spire Healthcare Group (CHIX:SPIL) Overvalued in 2026?
Based on GuruFocus' analysis, Spire Healthcare Group stock appears to be undervalued.
The current stock price of £2.33 is trading 15.6% below its estimated GF Value™ of £2.76.
GuruFocus considers Spire Healthcare Group to be Modestly Undervalued.
Key valuation signals for CHIX:SPIL:
EV-to-OCF: 9.15 (10% below median its 10-year median of 10.16)
GF Value™: £2.76 vs. price of £2.33 (15.6% below fair value)
Industry Position: 2.2% above the Healthcare Providers & Services median (#351 of 681)
No single metric tells the full story. See the CHIX:SPIL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Spire Healthcare Group PLC is an independent hospital group in the United Kingdom. It is a private provider, by volume, of knee and hip operations in the United Kingdom. The company has two operating segments: the hospitals business and the Primary care. The company generates the majority of its revenue from Hospital Business, which consists of hospitals, clinics, medical centres and consulting rooms. The company provide diagnostics, inpatient, day case and outpatient care in areas including orthopaedics, gynaecology, cardiology, neurology, oncology and general surgery. The primary care segment encompasses services focused on the primary care needs of outpatients, including GP services, occupational health services or mental and physical health services.
80GF Score
Get the complete analysis for CHIX:SPIL
EV-to-OCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CHIX:SPIL has been successfully added to your 
